TOKENPOST
1 min read
Add as a preferred source on Google

Chugai Pharmaceutical Posts ¥228.07 IFRS EPS for Nine Months

Revenue was ¥1,068.1 billion for the nine months ended Sept. 30, 2026. The results were dated Oct. 27.

By John Kim
Published
A blank report folio stands upright in a narrow red beam. / TokenPost.ai
A blank report folio stands upright in a narrow red beam. / TokenPost.ai

Chugai Pharmaceutical Co., Ltd. recorded IFRS basic and diluted earnings per share of ¥228.07 for the nine months ended Sept. 30, 2026.

Revenue for the period was ¥1,068.1 billion. The financial statements were dated Oct. 27, 2026.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…